Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial

Peer Review reports

Original Submission
28 Jul 2018	Submitted	Original manuscript
21 Oct 2018	Reviewed	Reviewer Report - Emily Peckham
7 Nov 2018	Author responded	Author comments - Tomohiro Koga
Resubmission - Version 2
7 Nov 2018	Submitted	Manuscript version 2
16 Nov 2018	Reviewed	Reviewer Report - Emily Peckham
19 Nov 2018	Author responded	Author comments - Tomohiro Koga
Resubmission - Version 3
19 Nov 2018	Submitted	Manuscript version 3
Publishing
5 Dec 2018	Editorially accepted
29 Dec 2018	Article published	10.1186/s13063-018-3105-6

Back to article page